All Pharma News
Replimune Reports FY 2024 Financials, Corporate Update

Replimune Reports FY 2024 Financials, Corporate Update
GLOBENEWSWIRE
16 May 2024
Share Share
Interim Results from the ARTACUS Trial will Presented at AACR

Interim Results from the ARTACUS Trial will Presented at AACR
GLOBENEWSWIRE
07 Apr 2024
Share Share
Replimune to Present at the American Association for Cancer Annual Meeting 2024

Replimune to Present at the American Association for Cancer Annual Meeting 2024
GLOBENEWSWIRE
06 Mar 2024
Share Share
Replimune Reports Fiscal Third Quarter 2024 Financial Results

Replimune Reports Fiscal Third Quarter 2024 Financial Results
GLOBENEWSWIRE
08 Feb 2024
Share Share
Replimune shares halve as skin cancer drug fails phase 2

Replimune shares halve as skin cancer drug fails phase 2
Annalee Armstrong FIERCE BIOTECH
05 Dec 2023
Share Share
Replimune Reports Fiscal Second Quarter 2024 Financial Results

Replimune Reports Fiscal Second Quarter 2024 Financial Results
GLOBENEWSWIRE
07 Nov 2023
Share Share
Replimune Presents Interim Results from the ARTACUS Clinical Trial of RP1

Replimune Presents Interim Results from the ARTACUS Clinical Trial of RP1
GLOBENEWSWIRE
03 Nov 2023
Share Share
Replimune Announces Appointment of Emily Hill as Chief Financial Officer

Replimune Announces Appointment of Emily Hill as Chief Financial Officer
GLOBENEWSWIRE
19 Sep 2023
Share Share
Replimune Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Replimune Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GLOBENEWSWIRE
19 Sep 2023
Share Share
Replimune Reports Fiscal First Quarter 2024 Financial Results

Replimune Reports Fiscal First Quarter 2024 Financial Results
GLOBENEWSWIRE
03 Aug 2023
Share Share